Skip to content
Saturday, 9 May 2026
Mukhyamantri
Business

Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin

Solid Intellectual Property Protection Across Four Continents Ahead of Pending Phase 3 Data Release HOUSTON, May 08, 2026 (GLOBE NEWSWIRE) -- Moleculin...

By Moleculin Biotech, Inc.· GlobeNewswire· 1 day ago· 2 min read
Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin